The challenges in diagnosis and management of Multiple Myeloma patients
The management of Multiple Myeloma and other B-Cell Dyscrasias is faced with many challenges including:
Standard practices rely on laboratory-based tests to provide information to the clinician for decision making. The time between taking blood samples and receiving laboratory results can vary from a few days to several weeks if the sample is referred to another testing laboratory for analysis of FLC.
Patients often have to go to the hospital to have their blood taken prior to seeing the Haematologist. The availability of a rapid test for FLC can reduce hospital visits and thus have economic savings.
There is an underlying requirement both for clinicians and patients for a test that can:
Use of Seralite®– FLC can facilitate:
*Please see Resources page for a full list of referencesContact us
Seralite®– FLC is not available for sale in the USA.
© Abingdon Health 2019